AGENDA - 23RD JULY 2001

1. Apologies for absence

2. Minutes of meeting on 26 April 2001 MUT/MIN/01/2

3. Matters arising:

3.1 Tobacco induced lung carcinogenesis: the importance of p53 mutations

4. COM Review of Dichlorvos:

4.1 2nd Draft COM statement: overview of issues raised by ACP
and Industry. MUT/01/19

4.2 Comments from industry on 1st draft Statement MUT/01/20

4.3 Overheads to be presented by industry MUT/01/21 Addendum: Critical in-vivo studies addendum MUT/01/21

4.4 Comparative data on Naled and Trichlorfon MUT/01/22

4.5 Comments from COC on carcinogenicity Bioassays MUT/01/23

4.6 Comments from industry on 1st draft

Statement as forwarded to ACP on 24 May 2001 MUT/01/24

5. Any other business

6. Date of next meeting: 11 October 2001